Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 21, 2005

Book review

Favourites:
ADD

Review article

Mechanism of Local Anesthetic Drug Action on Voltage-Gated Sodium Channels
pp. 2671-2686(16)
Authors: Fozzard, H. A.; Lee, P. J.; Lipkind, G. M.

Favourites:
ADD

Activation and Activators of TRPV1 and Their Pharmaceutical Implication
pp. 2687-2698(12)
Authors: Suh, Young-Ger; Oh, Uhtaek

Favourites:
ADD

Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels
pp. 2699-2716(18)
Authors: Bryan, J.; Crane, A.; Vila-Carriles, W. H.; Babenko, A. P.; Aguilar-Bryan, L.

Favourites:
ADD
Favourites:
ADD

Ion Channel Defects in Idiopathic Epilepsies
pp. 2737-2752(16)
Authors: Lerche, Holger; Weber, Yvonne G.; Jurkat-Rott, Karin; Lehmann-Horn, Frank

Favourites:
ADD
Favourites:
ADD

The TRPM Cation Channels in the Immune Context
pp. 2765-2778(14)
Authors: Schmitz, C.; Perraud, A.- L.

Favourites:
ADD

Beyond Single Pathway Inhibition: MEK Inhibitors as a Platform for the Development of Pharmacological Combinations with Synergistic Anti-Leukemic Effects
pp. 2779-2795(17)
Authors: Milella, M.; Precupanu, C. M.; Gregorj, C.; Ricciardi, M. R.; Petrucci, M. T.; Kornblau, S. M.; Tafuri, A.; Andreeff, M.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content